CMAX - CareMax, Inc. Stock Price, Fair Value and News

2.99USD+0.22 (+7.94%)Delayed

Market Summary

USD2.99+0.22

Delayed

7.94%

CMAX Alerts

Big jump in Revenue (Y/Y)

Big jump in Earnings (Y/Y)
Losses in recent quarter

CMAX Stock Price

View Fullscreen

CMAX RSI Chart

CMAX Valuation

Market Cap

11.3M

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.01

EV/EBITDA

0.05

Price/Free Cashflow

-0.18

CMAX Price/Sales (Trailing)

CMAX Profitability

EBT Margin

-79.66%

Return on Equity

-3.2K%

Return on Assets

-104.96%

Free Cashflow Yield

-543.64%

CMAX Fundamentals

CMAX Revenue

Revenue (TTM)

810.4M

Rev. Growth (Yr)

34.26%

Rev. Growth (Qtr)

52.96%

CMAX Earnings

Earnings (TTM)

-644.7M

Earnings Growth (Yr)

47.12%

Earnings Growth (Qtr)

90.68%

Breaking Down CMAX Revenue

Last 30 days

19.1%

Last 90 days

-32.0%

Trailing 12 Months

-96.4%

How does CMAX drawdown profile look like?

CMAX Financial Health

Current Ratio

0.31

Debt/Equity

0.09

Debt/Cashflow

-26.06

CMAX Investor Care

Shares Dilution (1Y)

1.79%

Diluted EPS (TTM)

-172.6

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	810.4M	0	0	0
2023	667.2M	719.4M	763.5M	751.1M
2022	404.8M	532.1M	585.2M	631.1M
2021	106.1M	125.3M	205.6M	295.8M
2020	93.8M	97.0M	100.2M	103.4M
2019	0	0	0	90.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of CareMax, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 17, 2023	de la torre ralph	acquired	-	-	10,927	-
Nov 17, 2023	oquinn ryan	acquired	-	-	12,123	-
Nov 17, 2023	berg kevin	acquired	-	-	12,123	-
Nov 17, 2023	flynn james e	acquired	-	-	12,123	-
Jun 08, 2023	wirges kevin	acquired	-	-	4,433	evp, treasurer and cfo
Jun 08, 2023	de solo carlos a.	acquired	-	-	14,300	president and ceo
Jun 08, 2023	de solo alberto	acquired	-	-	6,300	evp and coo
May 12, 2023	wirges kevin	acquired	-	-	10,632	evp, treasurer and cfo
May 12, 2023	shulkin david	acquired	-	-	18,585	-
May 12, 2023	rodriguez jose ramon	acquired	-	-	23,381	-

Which funds bought or sold CMAX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	new	-	1,195	1,195	-%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-15,858	-	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	sold off	-100	-6,163	-	-%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	added	2,900	210	374	-%
May 15, 2024	MORGAN STANLEY	new	-	1,676,140	1,676,140	-%
May 15, 2024	DEUTSCHE BANK AG\	sold off	-100	-331,622	-	-%
May 15, 2024	DEUTSCHE BANK AG\	new	-	36,695	36,695	-%
May 15, 2024	CITADEL ADVISORS LLC	sold off	-100	-42,204	-	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-48,677	-	-%
May 15, 2024	Royal Bank of Canada	new	-	1,000	1,000	-%

Are Funds Buying or Selling CMAX?

Are funds buying CMAX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CMAX

No. of Funds

Unveiling CareMax, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	eminence capital, lp	9.3%	10,424,657	SC 13G/A
Feb 12, 2024	morgan stanley	9.5%	10,648,800	SC 13G
Mar 13, 2023	deerfield management company, l.p. (series c)	16.37%	18,691,423	SC 13D/A
Feb 14, 2023	eminence capital, lp	9.4%	10,462,311	SC 13G/A
Feb 14, 2023	athyrium opportunities iii acquisition 2 lp	3.7%	4,167,881	SC 13G/A
Nov 22, 2022	de la torre ralph	16.3%	18,066,223	SC 13D
Nov 07, 2022	deerfield management company, l.p. (series c)	20.72%	18,691,423	SC 13D/A
Jun 02, 2022	deerfield management company, l.p. (series c)	20.72%	18,691,423	SC 13D/A
Feb 15, 2022	deerfield management company, l.p. (series c)	20.79%	18,691,423	SC 13D/A
Feb 14, 2022	eminence capital, lp	9.3%	8,079,616	SC 13G

Recent SEC filings of CareMax, Inc.

View All Filings

Date Filed	Form Type	Document
May 15, 2024	8-K	Current Report
May 13, 2024	10-Q/A	Quarterly Report
May 09, 2024	8-K	Current Report
May 09, 2024	10-Q	Quarterly Report
Apr 29, 2024	10-K/A	Annual Report
Mar 18, 2024	NT 10-K	NT 10-K
Mar 18, 2024	8-K	Current Report
Mar 18, 2024	10-K	Annual Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	SC 13G	Major Ownership Report

Peers (Alternatives to CareMax, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

CareMax, Inc. News

Latest updates

CareMax, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	53.0%	232,246,000	151,835,500	201,843,000	224,440,000	172,983,000	164,263,000	157,670,000	172,279,000	136,920,000	118,305,500	104,620,000	44,919,000	27,918,000	28,113,518	24,306,000	25,795,000	25,179,964	-
Operating Expenses	-58.0%	253,951,000	604,842,000	292,615,000	228,191,000	281,606,000	250,497,500	166,222,000	178,767,000	147,811,000	127,981,500	115,849,000	54,643,000	26,112,000	25,902,692	24,200,000	21,928,000	21,681,617	-
S&GA Expenses	-16.8%	3,064,000	3,681,000	3,501,000	3,327,000	3,765,000	3,806,000	2,355,000	2,299,000	3,301,000	2,615,000	1,274,000	775,000	291,000	256,000	311,000	272,000	5,524,251	-
EBITDA Margin	13.5%	-0.72	-0.83	-0.22	-0.13	-0.12	-0.04	-0.04	-0.03	0.00	0.04	0.09	0.09	0.10	0.10	-	-	-	-
Interest Expenses	-19.5%	8,915,000	11,068,000	8,630,000	8,234,000	6,375,000	5,228,000	3,800,000	2,416,000	1,353,000	2,106,000	1,376,000	437,000	504,000	436,000	-	487,530	327,470	-
Income Taxes	112.6%	177,000	-1,406,000	200,000	177,000	177,000	-20,089,000	181,000	200,000	181,000	159,000	-	-	-	-	-	-	-	-
Earnings Before Taxes	90.7%	-43,231,000	-467,162,000	-102,946,000	-32,199,000	-81,904,000	-9,639,000	-21,872,000	-9,210,000	-16,616,000	-3,396,000	-14,479,000	10,057,000	1,302,000	-	-281,000	3,464,000	-	-
EBT Margin	12.6%	-0.80	-0.91	-0.30	-0.20	-0.18	-0.09	-0.09	-0.08	-0.06	-0.02	0.04	0.06	0.07	0.07	-	-	-	-
Net Income	90.7%	-43,408,000	-465,767,000	-103,123,000	-32,376,000	-82,082,000	10,434,500	-22,053,000	-9,381,000	-16,797,000	-3,555,000	-14,479,000	10,057,000	1,302,000	-20,102,346	-315,000	3,464,000	3,171,000	-
Net Income Margin	12.6%	-0.80	-0.91	-0.27	-0.18	-0.15	-0.06	-0.09	-0.08	-0.06	-0.02	-0.11	-0.07	-0.15	0.07	0.06	0.06	0.06	0.06
Free Cashflow	-368.0%	-23,928,000	8,929,000	-21,956,000	-24,465,000	-24,032,000	-30,993,000	-14,382,000	-16,685,000	-13,606,000	-16,078,000	-7,258,000	-6,192,000	1,682,000	-440,879	1,907,000	-204,258	-21,516	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																	(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Assets	-1.5%	614	623	1,058	1,151	1,098	1,171	707	709	649	653	666	633	41.00	39.00	145	85.00	24.00
Current Assets	-14.9%	156	183	177	219	210	197	145	147	93.00	95.00	119	208	16.00	15.00	1.00	0.00	10.00
Cash Equivalents	-36.7%	41.00	66.00	32.00	55.00	44.00	42.00	53.00	68.00	33.00	48.00	80.00	172	6.00	5.00	10.00	11.00	4.00
Inventory	-	-	-	-	-	-	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	-	-	0.00
Net PPE	-1.4%	47.00	48.00	28.00	25.00	23.00	21.00	18.00	17.00	17.00	16.00	16.00	13.00	6.00	5.00	-	-	3.00
Goodwill	0%	157	157	523	603	603	701	465	465	464	465	452	359	-	10.00	-	-	6.00
Liabilities	5.7%	594	562	534	526	558	551	238	221	157	148	159	243	33.00	32.00	13.00	-	19.00
Current Liabilities	15.6%	507	439	98.00	98.00	80.00	77.00	34.00	27.00	28.00	22.00	23.00	62.00	6.00	5.00	0.00	1.00	3.00
Long Term Debt	-91.2%	2.00	21.00	303	298	261	231	184	182	110	111	113	114	26.00	26.00	-	-	16.00
LT Debt, Current	7.3%	391	364	-	-	-	31.00	0.00	0.00	6.00	6.00	6.00	7.00	1.00	1.00	-	-	1.00
LT Debt, Non Current	-100.0%	-	21.00	303	298	261	231	184	182	110	111	113	114	26.00	26.00	-	-	16.00
Shareholder's Equity	-66.8%	20.00	61.00	525	624	540	620	469	488	492	505	506	390	8.00	7.00	11.00	11.00	5.00
Retained Earnings	-6.0%	-764	-720	-255	-152	-119	-37.59	-48.20	-26.14	-16.76	0.00	4.00	18.00	-12.21	-	-1.41	-0.03	-
Additional Paid-In Capital	0.3%	785	782	780	777	659	657	517	514	509	505	503	372	17.00	-	6.00	0.00	-
Shares Outstanding	1.4%	4.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	2.00	1.00	1.00	0.00	0.00	0.00	0.00	-
Float	-	-	-	-	226	-	-	-	223	-	-	-	688	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	-253.2%	-23,802	15,533	-19,183	-21,517	-21,746	-28,405	-12,413	-15,259	-12,139	-15,055	-5,818	-6,355	3,372	-78.88	2,104	-	1,366	-
Share Based Compensation	-8.9%	2,365	2,595	3,242	2,464	2,298	2,785	3,611	2,788	1,087	375	966	-	-	-	-	-	-	-
Cashflow From Investing	98.1%	-126	-6,604	-2,773	-2,948	-2,286	-57,533	-2,076	-1,426	-1,467	-15,268	-89,532	-210,089	-1,690	-	-3,235	-254	-1,604	-
Cashflow From Financing	-100.5%	-119	24,336	-386	34,850	26,627	74,249	-326	52,075	-1,570	-2,212	3,766	382,045	-181	-2,113	1,560	206	2,470	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CMAX Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 232,246	$ 172,983
Operating Expenses
External provider costs	180,941	110,673
Cost of care	43,133	38,627
Sales and marketing	3,064	3,765
Corporate, general and administrative	20,108	23,965
Depreciation and amortization	6,705	6,576
Goodwill impairment	0	98,000
Total operating expenses	253,951	281,606
Operating loss	(21,705)	(108,623)
Nonoperating (expenses) income
Interest expense	(19,756)	(10,711)
Change in fair value of derivative liabilities	(2,381)	1,107
Gain on remeasurement of contingent earnout liabilities	0	36,136
Other income, net	610	187
Total nonoperating (expenses) income	(21,526)	26,718
Loss before income tax	(43,231)	(81,904)
Income tax expense	(177)	(177)
Net loss	$ (43,408)	$ (82,082)
Weighted average basic shares outstanding	3,778,600	3,712,027
Weighted average diluted shares outstanding	3,778,600	3,712,027
Net loss per share
Basic	$ (11.49)	$ (22.11)
Diluted	$ (11.49)	$ (22.11)
Medicare
Revenue
Total revenue	$ 168,502	$ 121,593
Medicaid
Revenue
Total revenue	37,653	25,626
Government Value
Revenue
Total revenue	18,815	10,010
Other Revenue
Revenue
Total revenue	$ 7,276	$ 15,754

CMAX Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 41,479	$ 65,528
Accounts receivable, net	107,985	114,754
Other current assets	6,650	3,066
Total Current Assets	156,113	183,348
Property and equipment, net	47,243	47,918
Operating lease right-of-use assets	109,947	109,215
Goodwill, net	156,841	156,841
Intangible assets, net	96,092	101,243
Other assets	47,965	24,737
Total Assets	614,202	623,301
Current Liabilities
Accounts payable	6,704	6,275
Accrued expenses	20,172	16,224
Risk settlement liabilities	53,599	42,602
Related party liabilities	1,229	190
Current portion of third-party debt, net	390,995	364,380
Current portion of operating lease liabilities	32,062	8,975
Other current liabilities	2,354	165
Total Current Liabilities	507,114	438,812
Derivative liabilities	49	22
Long-term debt, net	1,879	21,443
Long-term operating lease liabilities	78,417	97,136
Other liabilities	6,340	4,443
Total Liabilities	593,800	561,856
COMMITMENTS AND CONTINGENCIES (NOTE 14)
STOCKHOLDERS' EQUITY
Preferred stock (1,000,000 shares authorized; one share issued and outstanding as of March 31, 2024 and December 31, 2023)
Class A common stock ($0.0001 par value; 8,333,333 shares authorized; 3,802,883 and 3,744,732 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively)	11	11
Additional paid-in-capital	784,736	782,371
Accumulated deficit	(764,345)	(720,938)
Total Stockholders' Equity	20,403	61,444
Total Liabilities and Stockholders' Equity	$ 614,202	$ 623,301

About CareMax, Inc.

CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, Tennessee, Texas, and New York. The company is headquartered in Miami, Florida.

CEO	Mr. Carlos A. de Solo
WEBSITE	caremax.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1500

CareMax, Inc. Frequently Asked Questions

What is the ticker symbol for CareMax, Inc.? What does CMAX stand for in stocks?

CMAX is the stock ticker symbol of CareMax, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CareMax, Inc. (CMAX)?

As of Fri May 17 2024, market cap of CareMax, Inc. is 11.3 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CMAX stock?

You can check CMAX's fair value in chart for subscribers.

What is the fair value of CMAX stock?

You can check CMAX's fair value in chart for subscribers. The fair value of CareMax, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CareMax, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CMAX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CareMax, Inc. a good stock to buy?

The fair value guage provides a quick view whether CMAX is over valued or under valued. Whether CareMax, Inc. is cheap or expensive depends on the assumptions which impact CareMax, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CMAX.

What is CareMax, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, CMAX's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CMAX PE ratio will change depending on the future growth rate expectations of investors.